← Back to stories

Global wildlife trade amplifies zoonotic spillover risks: systemic drivers of pathogen spillover in traded mammal species

Mainstream coverage frames zoonotic spillover as an inevitable consequence of wildlife trade, obscuring how colonial-era extraction logics, neoliberal supply chains, and weak regulatory harmonisation at WTO and CITES levels enable systemic pathogen exchange. The 40% pathogen-sharing rate among traded mammals versus 6% in non-traded species reveals structural incentives—cheap global transport, lax biosecurity, and demand for exotic pets—that prioritise profit over biosafety. Indigenous and local communities, often framed as vectors, are instead disproportionately impacted by these spillovers while lacking agency in decision-making.

⚡ Power-Knowledge Audit

The narrative is produced by Western scientific institutions (Nature, funded by Wellcome Trust, Gates Foundation) and serves global biosecurity elites, pharmaceutical corporations, and conservation NGOs who benefit from framing spillover as a 'natural' risk to be managed through surveillance and technofixes (e.g., vaccines, AI tracking). The framing obscures how colonial-era wildlife trade routes (e.g., 19th-century specimen collection) laid the groundwork for today’s globalised markets, and how CITES and WTO rules prioritise trade liberalisation over biosafety. Indigenous knowledge holders and local farmers—who have coexisted with these pathogens for millennia—are sidelined in favor of Western epidemiological models.

📐 Analysis Dimensions

Eight knowledge lenses applied to this story by the Cogniosynthetic Corrective Engine.

🔍 What's Missing

The original framing omits the role of colonial-era wildlife trade networks in establishing today’s global supply chains, the historical continuity of pathogen spillover from colonial-era hunting to modern exotic pet markets, and the disproportionate burden on Indigenous and rural communities who bear the health and economic costs of spillovers. It also ignores traditional ecological knowledge (TEK) on disease avoidance and local adaptive practices, as well as the structural racism embedded in global health surveillance systems that privilege Western labs over local knowledge. Additionally, the piece fails to contextualise spillover within broader biodiversity loss and habitat fragmentation driven by agribusiness and extractive industries.

An ACST audit of what the original framing omits. Eligible for cross-reference under the ACST vocabulary.

🛠️ Solution Pathways

  1. 01

    Decolonise Global Health Governance

    Reform CITES and WTO rules to prioritise biosafety over trade liberalisation, including mandatory Indigenous representation in decision-making bodies and binding agreements to phase out high-risk wildlife trade (e.g., exotic pets, luxury wildlife products). Establish a Global South-led zoonotic surveillance fund to support community-based monitoring, ensuring that local knowledge systems are integrated into early warning systems. Pressure pharmaceutical corporations to share pathogen data and benefits equitably with Indigenous communities, as mandated by the Nagoya Protocol.

  2. 02

    Support Indigenous-Led Conservation and Health Systems

    Fund Indigenous-led conservation initiatives that combine traditional ecological knowledge with modern biosurveillance, such as the Māori-led 'Kaitiaki' (guardian) networks in Aotearoa/New Zealand. Invest in Indigenous health systems that integrate zoonotic risk mitigation with primary care, leveraging practices like the Amazon’s 'susto' (fright) healing ceremonies to address trauma linked to ecological disruption. Strengthen land tenure rights for Indigenous peoples, as secure land rights are proven to reduce deforestation and wildlife trade.

  3. 03

    Regulate Global Wildlife Supply Chains

    Implement mandatory biosecurity standards for wildlife traders, including traceability systems for all traded species and penalties for illegal trade. Ban high-risk wildlife products (e.g., pangolins, civets) in luxury markets, while supporting alternative livelihoods for communities dependent on wildlife trade. Partner with local cooperatives to develop sustainable, low-risk wildlife products (e.g., non-timber forest products) that reduce pressure on high-risk species.

  4. 04

    Promote One Health Education and Research

    Expand university curricula to include One Health frameworks that integrate veterinary, medical, and ecological sciences with Indigenous knowledge. Fund interdisciplinary research that centres marginalised voices, such as the 'Health in Harmony' initiative in Borneo, which combines Western medicine with local ecological practices. Support artistic and spiritual initiatives that reframe human-wildlife relationships, such as the 'Animist Ecology' movement in Latin America.

🧬 Integrated Synthesis

The 40% pathogen-sharing rate among traded mammals is not an accident but the predictable outcome of a globalised trade system built on colonial extraction, neoliberal deregulation, and epistemic violence against Indigenous knowledge. Historical precedents—from 19th-century colonial specimen collection to 20th-century exotic pet markets—reveal how extractive logics persist under new guises, while contemporary actors like CITES and WTO prioritise trade over biosafety. The framing of spillover as an inevitable 'natural' risk obscures how marginalised communities, particularly Indigenous peoples and rural farmers, are both disproportionately impacted by and excluded from solutions to this crisis. Indigenous cosmologies and TEK offer not just alternative perspectives but actionable frameworks for prevention, yet these are systematically sidelined in favor of Western technofixes. A systemic response requires decolonising global health governance, regulating wildlife supply chains, and centering Indigenous leadership in conservation and health systems—while acknowledging that the root causes of spillover are not biological but political and economic.

🔗